SCOTT D SANDELL
CIK 1237289 · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$22.82B
Companies
79
Total Filings
314
Lifetime Open-Market Net
-$149.76M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NET | Director | 185,912 | $264.10 | $49.10M | -$139.03M | 26 | 2026-07-02 |
| COUR | Director | 2,312,113 | $5.85 | $13.53M | $0 | 12 | 2026-06-15 |
| KRRO | 10%+ Owner | 1,297,893 | $10.50 | $13.63M | $3.30M | 2 | 2026-03-12 |
| SGP | 10%+ Owner | 5,097,538 | $21.62 | $110.21M | $15.00M | 1 | 2026-02-11 |
| NeueHealth, Inc. (BHG) Delisted | Director | 674,830 | $16.35 | $11.03M | $34.97M | 8 | 2025-10-06 |
| SNTI | 10%+ Owner | 3,775,615 | $0.38 | $1.44M | $0 | 1 | 2025-03-12 |
| NeueHealth, Inc. (NEUE) Delisted | 10%+ Owner | — | $6.75 | — | $0 | 2 | 2024-10-03 |
| MBX | 10%+ Owner | 1,023,103 | $60.06 | $61.45M | $8.00M | 1 | 2024-09-17 |
| SGMT | 10%+ Owner | 3,000,275 | $7.27 | $21.81M | $0 | 1 | 2024-01-31 |
| SVRA | 10%+ Owner | 24,471,264 | $5.33 | $130.43M | $1000.0K | 1 | 2023-07-19 |
| MIRM | 10%+ Owner | 163 | $112.23 | $18.3K | $6.75M | 2 | 2023-06-15 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | 10%+ Owner | 22,372 | $15.70 | $351.2K | -$5.04M | 6 | 2023-01-27 |
| Arcellx, Inc. (ACLX) Delisted | 10%+ Owner | 6,746,494 | $115.07 | $776.32M | $39.98M | 3 | 2022-12-27 |
| Akouos, Inc. (AKUS) Delisted | 10%+ Owner | 0 | $13.29 | $0 | $10.00M | 2 | 2022-12-02 |
| IONQ.WS | 10%+ Owner | 1,141 | $22.45 | $25.6K | $0 | 1 | 2022-11-18 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | 10%+ Owner | 386 | $15.00 | $5.8K | $24.62M | 17 | 2022-10-21 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | 10%+ Owner | 0 | $0.00 | $0 | $21.03M | 4 | 2022-05-26 |
| HOOD | Director | 0 | $92.76 | $0 | -$123.2K | 9 | 2022-05-16 |
| TRVI | 10%+ Owner | 10,421,428 | $18.43 | $192.07M | $31.80M | 4 | 2022-04-13 |
| IMRA | 10%+ Owner | 716,628 | $14.49 | $10.38M | -$6.01M | 1 | 2022-04-07 |
| BE | Director | 55,751 | $166.84 | $9.30M | $20.00M | 14 | 2022-04-01 |
| Casper Sleep Inc. (CSPR) Delisted | 10%+ Owner | 0 | $6.78 | $0 | $0 | 1 | 2022-01-26 |
| ARDX | 10%+ Owner | 47 | $5.08 | $239 | $80.74M | 13 | 2021-12-27 |
| Metacrine, Inc. (MTCR) Delisted | 10%+ Owner | 2,563,257 | $0.49 | $1.27M | $9.51M | 2 | 2021-12-27 |
| CVRX | 10%+ Owner | 1,800,583 | $4.95 | $8.91M | $9.01M | 1 | 2021-07-07 |
| GLUE | 10%+ Owner | 7,692,298 | $22.04 | $169.54M | $19.95M | 1 | 2021-06-30 |
| Desktop Metal, Inc. (DM) Delisted | 10%+ Owner | 554 | $4.96 | $2.7K | $0 | 1 | 2021-06-10 |
| Eargo, Inc. (EAR) Delisted | 10%+ Owner | 10 | $2.57 | $26 | $5.60M | 2 | 2021-05-26 |
| MRKR | 10%+ Owner | 1,071,428 | $1.18 | $1.26M | $10.00M | 1 | 2021-03-18 |
| Regulus Therapeutics Inc. (RGLS) Delisted | 10%+ Owner | 645,106 | $8.16 | $5.26M | $3.96M | 3 | 2020-12-07 |
| SPT | 10%+ Owner | 165,945 | $8.69 | $1.44M | $0 | 1 | 2020-11-17 |
| Mersana Therapeutics, Inc. (MRSN) Delisted | 10%+ Owner | 478,791 | $29.08 | $13.92M | $14.77M | 5 | 2020-09-16 |
| Inozyme Pharma, Inc. (INZY) Delisted | 10%+ Owner | 2,187,689 | $4.00 | $8.75M | $4.00M | 1 | 2020-07-28 |
| NKTX | 10%+ Owner | 2,235,449 | $2.22 | $4.96M | $12.00M | 1 | 2020-07-16 |
| SENS | 10%+ Owner | 993,368 | $4.91 | $4.88M | $27.21M | 5 | 2020-04-23 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | 10%+ Owner | 19,500,000 | $0.06 | $1.13M | $5.00M | 1 | 2020-01-28 |
| TESARO, Inc. (TSRO) Delisted | 10%+ Owner | 0 | — | — | $73.03M | 7 | 2019-01-22 |
| ESTC | 10%+ Owner | 655,522 | $62.10 | $40.71M | $0 | 1 | 2018-10-10 |
| ASND | 10%+ Owner | 82,978,668 | $254.44 | $21.11B | $49.02M | 4 | 2018-09-10 |
| Surface Oncology, Inc. (SURF) Delisted | 10%+ Owner | 3,179,544 | $1.07 | $3.40M | $2.00M | 1 | 2018-04-23 |
| Oruka Therapeutics, Inc. (ABIO) Delisted | 10%+ Owner | 0 | $28.80 | $0 | -$731.3K | 1 | 2018-02-27 |
| Cascadian Therapeutics, Inc. (CASC) Delisted | 10%+ Owner | 10,882,574 | — | — | $0 | 1 | 2018-02-22 |
| APPN | 10%+ Owner | 9,628 | $27.35 | $263.3K | -$66.07M | 4 | 2018-02-15 |
| SYNLOGIC, INC. (SYBX) Delisted | 10%+ Owner | 281,929 | $0.69 | $194.5K | $0 | 2 | 2018-01-26 |
| Care.com Inc (CRCM) Delisted | 10%+ Owner | 504 | — | — | $0 | 2 | 2017-11-08 |
| RYTM | 10%+ Owner | 4,359,956 | $108.04 | $471.05M | $9.35M | 1 | 2017-10-10 |
| MULESOFT, INC (MULE) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2017-03-22 |
| Zosano Pharma Corp (ZSAN) Delisted | 10%+ Owner | 1,361 | $0.56 | $759 | -$13.80M | 4 | 2017-02-14 |
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 5,215,128 | — | — | $6.75M | 1 | 2016-12-19 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | 10%+ Owner | 1,858,450 | — | — | $4.39M | 1 | 2016-10-31 |
| Roka BioScience, Inc. (ROKA) Delisted | 10%+ Owner | 321,681 | — | — | $4.60M | 3 | 2016-09-30 |
| TriVascular Technologies, Inc. (TRIV) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2016-02-04 |
| Epizyme, Inc. (EPZM) Delisted | 10%+ Owner | 5,854,351 | $1.47 | $8.61M | $23.87M | 4 | 2016-01-12 |
| SUPN | 10%+ Owner | 6,241,250 | $47.73 | $297.89M | $216.13M | 4 | 2015-11-12 |
| Avalo Therapeutics, Inc. (CERC.U) Delisted | 10%+ Owner | 594,245 | — | — | $0 | 1 | 2015-10-20 |
| SYNLOGIC, INC. (MIRN) Delisted | 10%+ Owner | 1,241,650 | — | — | $6.00M | 1 | 2015-10-06 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | 10%+ Owner | 8,250 | — | — | $0 | 1 | 2015-07-02 |
| BOX | 10%+ Owner | 0 | $31.50 | $0 | $0 | 1 | 2015-01-29 |
| Tableau Software Inc (DATA) Delisted | Director | 55,705 | — | — | -$600.28M | 14 | 2014-12-08 |
| CVENT INC (CVT) Delisted | 10%+ Owner | 1,009 | $8.52 | $8.6K | -$46.31M | 5 | 2014-11-28 |
| DERM | 10%+ Owner | 3,433,810 | $6.31 | $21.67M | $1.11M | 1 | 2014-10-08 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | 10%+ Owner | 1,376,495 | $18.62 | $25.63M | -$6.84M | 2 | 2014-08-29 |
| Loxo Oncology, Inc. (LOXO) Delisted | 10%+ Owner | 1,789,420 | — | — | $3.00M | 1 | 2014-08-06 |
| WDAY | Director | 9,490 | $159.69 | $1.52M | -$1.53M | 6 | 2014-03-04 |
| BOINGO WIRELESS, INC. (WIFI) Delisted | 10%+ Owner | 4,467,960 | $13.99 | $62.51M | -$27.4K | 2 | 2013-12-12 |
| FUSION-IO, INC. (FIO) Delisted | Director | 7,053,379 | — | — | -$44.65M | 19 | 2013-11-21 |
| AUDIENCE INC (ADNC) Delisted | 10%+ Owner | 1,016 | — | — | -$75.0K | 3 | 2013-11-06 |
| XOOM Corp (XOOM) Delisted | 10%+ Owner | 2,239,385 | — | — | $0 | 1 | 2013-10-31 |
| GRPN | 10%+ Owner | 0 | $28.10 | $0 | -$345.4K | 2 | 2013-09-17 |
| Clovis Oncology, Inc. (CLVS) Delisted | 10%+ Owner | 575 | $0.08 | $47 | $17.11M | 2 | 2013-06-05 |
| CHANNELADVISOR CORP (ECOM) Delisted | 10%+ Owner | 2,765,599 | $23.09 | $63.86M | $0 | 1 | 2013-05-29 |
| Millennial Media Inc. (MM) Delisted | 10%+ Owner | 8,196,614 | — | — | -$21.48M | 2 | 2012-10-30 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | 10%+ Owner | 1,513,927 | — | — | $5.00M | 1 | 2012-08-02 |
| INNERWORKINGS INC (INWK) Delisted | 10%+ Owner | 4,529,190 | — | — | -$12.65M | 7 | 2012-03-30 |
| ECHO | 10%+ Owner | 901 | $85.93 | $77.4K | $0 | 1 | 2012-03-01 |
| VG | 10%+ Owner | 4,558,701 | $12.17 | $55.48M | $0 | 1 | 2011-03-15 |
| INHIBITEX, INC. (INHX) Delisted | 10%+ Owner | 6,898,294 | — | — | $3.00M | 1 | 2009-10-30 |
| Data Domain, Inc. (DDUP) Delisted | Director | 43,750 | — | — | -$27.33M | 12 | 2009-07-21 |
| TNDM | 10%+ Owner | 592,747 | $17.76 | $10.53M | $0 | 1 | 2007-11-09 |
Recent Filings · Page 2 of 32
314 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-05 | NET | Grant (A) | +3,039 | $0 | EDGAR |
| 2024-05-24 | COUR | Grant (A) | +18,669 | $0 | EDGAR |
| 2024-05-15 | — | U | −126,479,591 | $0 | |
| 2024-04-24 | KRRO | Buy (P) | +17,857 | $1000.0K | EDGAR |
| 2024-04-10 | NeueHealth, Inc. (NEUE) Delisted | Buy (P) | — | $0 | EDGAR |
| 2024-01-31 | SGMT | Other (J) | −843,003 | $0 | EDGAR |
| 2023-12-21 | NeueHealth, Inc. (BHG) Delisted | Buy (P) | — | $0 | EDGAR |
| 2023-11-22 | NET | Sell (S) | −211,534 | -$15.48M | EDGAR |
| 2023-11-16 | NET | Gift (G) | −10,283 | $0 | EDGAR |
| 2023-11-06 | COUR | Gift (G) | −24,695 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.